SCHEMBL28790025

SCHEMBL28790025

FC(F)(F)c1n[nH]c(N2CCNCC2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB1 P08588 3/20 0.41
▸ ADRB2 P07550 3/20 0.39
▸ EPHX2 P34913 1/20 0.37
▸ HRH1 P35367 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ USP2 O75604 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ HTR2C P28335 3/20 0.36
▸ HTR3A P46098 2/20 0.36
▸ PIM1 P11309 2/20 0.36
▸ HTR1D P28221 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HTR3E A5X5Y0 1/20 0.36
▸ HTR3B O95264 1/20 0.36
▸ HTR3D Q70Z44 1/20 0.36
▸ HTR3C Q8WXA8 1/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36
▸ MAPT P10636 1/20 0.35
▸ THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18135535 0.72 HRH4 (0.46) ADRB2HRH1KDM4EUSP2SMN1; SMN2
SCHEMBL18135541 0.72 HRH1 (0.41) ADRB1ADRB2HRH1KDM4EUSP2
SCHEMBL16846204 0.71 HRH1 (0.37) ADRB1HRH1USP2SMN1; SMN2TDP1
Hydrochloric Acid SCHEMBL16825844 0.70 HRH4 (0.44) HRH1KDM4EUSP2SMN1; SMN2TDP1
SCHEMBL3151896 0.67 DPP4 (0.45) ADRB1ADRB2EPHX2HRH1KDM4E
SCHEMBL3922776 0.66 CHRNB2 (0.54) ADRB1ADRB2EPHX2HTR2CHTR3A
SCHEMBL2850464 0.65 HRH3 (0.59) ADRB1ADRB2EPHX2KDM4EUSP2
SCHEMBL13741399 0.64 ADRB2 (0.48) ADRB1ADRB2HRH1SMN1; SMN2HTR2C
SCHEMBL15375204 0.62 KDM4E (0.32) KDM4E
SCHEMBL24963015 0.62 ADRB1 (0.66) ADRB1ADRB2HRH1KDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101952286-A Bicyclic derivatives for use in the treatment of androgen receptor associated conditions ASTRAZENECA AB 2011-01-19 — — CN disclosed
Send feedback